Vmrd Inc.

Pullman, WA

UEI
SLKKCGGPSDS9
CAGE
38MG1
Primary NAICS
325413 In-Vitro Diagnostic Substance Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
Corporate family
SAM.gov registration date
Physical address
425 NW Albion Dr, Pullman, WA 99163, USA
Website
vmrd.com
Founded
1981
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Vmrd Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Firm fixed price delivery order for foot and mouth disease (FMD) enzyme linked immunosorbent assay (elisa) kits. Contract · 12639526F0624 Marketing and Regulatory Programs Business Services $3,060,000
Theileria equi and babesia caballi test kits Contract · 12639526F0172 Marketing and Regulatory Programs Business Services $229,636
Theileria equi and babesia caballi test kits Contract · 12639526F0004 Marketing and Regulatory Programs Business Services $41,064
Antibody test kits Contract · 12639525F0312 Marketing and Regulatory Programs Business Services $234,187
Antibody test kits Contract · 12639525F0095 Marketing and Regulatory Programs Business Services $86,322

About Vmrd Inc.

Vmrd Inc., a for-profit Pullman, Washington-based manufacturer of veterinary diagnostic test kits, operates exclusively as a federal prime contractor (100% of recent awards) supplying diagnostic products to the U.S. Department of Agriculture's Animal and Plant Health Inspection Service (APHIS) Veterinary Services. The company competes in full-and-open federal procurements without set-aside designations across most of its portfolio, though recent BPA calls under a $2 million blanket purchase agreement carry Total Small Business set-aside designations.

Vmrd's federal capability footprint centers entirely on animal disease surveillance and import-compliance diagnostics. The company manufactures Enzyme-Linked Immunosorbent Assay (ELISA) kits and antibody test kits for detection of equine parasitic diseases—specifically Theileria equi, Babesia caballi, and foot and mouth disease (FMD)—supporting APHIS's disease surveillance, monitoring, eradication, and import testing programs. Recent representative work includes a $3.06 million delivery order (awarded July 9, 2026) for FMD ELISA kits with performance completion by September 8, 2026; a $229,635.60 BPA call (January 21, 2026, Total Small Business set-aside) for Theileria equi and Babesia caballi test kits; and a $187,350 purchase order (May 25, 2023, no set-aside) for diagnostic test kits for Babesia caballi and Theileria equi detection. Performance occurs at APHIS facilities in Ames, Iowa and Pullman, Washington.

Customer concentration is extreme: APHIS Veterinary Services accounts for 87 of 112 total awards and $6.1 million of the $8.6 million combined potential value (71% of dollars). The next three agencies—APHIS proper, APHIS Headquarters, and the Agricultural Research Service—collectively represent only 6 awards and $2.2 million. Vmrd has served APHIS Veterinary Services as a sustained single-source supplier since 2005, with no identified subcontractors across its federal footprint.

Vmrd holds three active parent vehicles. A $2 million Blanket Purchase Agreement (effective February 1, 2024 through January 31, 2029) has generated 24 task orders worth $512 thousand; an older IDC (12639522D0063) produced 5 task orders worth $284 thousand before expiration in May 2023; and a newly awarded single-award Indefinite Delivery Contract (June 8, 2026, ceiling $352,393.50 through April 30, 2031) anchors FMD ELISA stockpiling for the National Animal Vaccine and Veterinary Countermeasures Bank. Awards activity has declined from five in 2022 to two in 2025, with three awards issued to date in 2026. One award valued at $3.1 million faces ultimate completion within the next twenty-four months—the new FMD ELISA IDC's base ordering period, creating recompete exposure if the contract is competed.

Primary NAICS classification is In-Vitro Diagnostic Substance Manufacturing (59 awards), with secondary categories in Analytical Laboratory Instrument Manufacturing and Biological Product Manufacturing. The company's federal revenue profile—112 awards with $6 million obligated against $8.6 million combined potential value (70% obligation rate)—reflects a mature, repetitive procurement relationship anchored to a single, highly specialized customer with recurring annual diagnostic product needs.

Quick answers

What is Vmrd Inc.'s UEI?

Vmrd Inc.'s Unique Entity ID (UEI) in SAM.gov is SLKKCGGPSDS9.

What is Vmrd Inc.'s CAGE code?

Vmrd Inc.'s CAGE code is 38MG1.

What is Vmrd Inc.'s primary NAICS code?

Vmrd Inc.'s primary NAICS code is 325413 (In-Vitro Diagnostic Substance Manufacturing).

Where is Vmrd Inc. located?

Vmrd Inc.'s physical address in SAM.gov is 425 NW Albion Dr, Pullman, WA 99163, USA.

Is Vmrd Inc. registered in SAM.gov?

Yes. Vmrd Inc.'s SAM.gov registration is active through March 27, 2027.

What is Vmrd Inc.'s most recent federal award?

Vmrd Inc.'s most recent federal contract award is Firm fixed price delivery order for foot and mouth disease (FMD) enzyme linked immunosorbent assay (elisa) kits (12639526F0624), from Marketing and Regulatory Programs Business Services, on July 9, 2026.

On GovTribe

See Vmrd Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors